{
    "2019-07-29": [
        [
            {
                "time": "",
                "original_text": "掉队公司后来居上：微芯生物发行价20.43元 周三打新",
                "features": {
                    "keywords": [
                        "微芯生物",
                        "发行价",
                        "打新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复宏汉霖“融资研发”模式恐难长久 多款产品面临“夹击”",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "融资研发",
                        "产品夹击"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "96个注射剂“搅局”6000亿市场 33个品种年销超10亿",
                "features": {
                    "keywords": [
                        "注射剂",
                        "市场",
                        "品种"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "事件驱动型量化基金，能长期跑赢市场吗？",
                "features": {
                    "keywords": [
                        "事件驱动",
                        "量化基金",
                        "跑赢市场"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药|行业周报】：行业增速平稳，关注科创方向",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "科创方向"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "以辅仁药业为例，谈暴雷迹象的认定与否定",
                "features": {
                    "keywords": [
                        "辅仁药业",
                        "暴雷",
                        "迹象"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:医药科创板“首秀”靓丽，选择优质公司是关键",
                "features": {
                    "keywords": [
                        "医药生物",
                        "科创板",
                        "首秀",
                        "优质公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}